Immunohistochemical and immunoradiometric evaluations of total cathepsin D in human larynx

Barret, 1979, Human cathepsin D, Adv Exp Med Biol, 95, 291, 10.1007/978-1-4757-0719-9_17 Contractor, 1982, Purification and properties of human placental cathepsin D, Placenta, 3, 45, 10.1016/S0143-4004(82)80017-9 Pohl, 1981, Isolation and characterization of cathepsin D from human gastric mucosa, Coll Czech Chem Commun, 46, 3302, 10.1135/cccc19813302 Zeillinger, 1992, Expression of cathepsin D in head and neck cancer, Eur J Cancer, 28A, 1413, 10.1016/0959-8049(92)90533-8 Rochefort, 1987, Estrogen-induced lysosomal proteases secreted by breast cancer cells: a role in carcinogenesis?, J Cell Biochem, 35, 17, 10.1002/jcb.240350103 Morisset, 1986, Processing and oestrogen regulation of the 52-kDa protein inside MCF7 breast cancer cells, Endocrinology, 119, 2773, 10.1210/endo-119-6-2773 Westley, 1980, A secreted glycoprotein induced by oestrogen in human breast cancer cell lines, Cell, 20, 353, 10.1016/0092-8674(80)90621-2 Marsigliante, 1992, Relation of cathepsin D level to the oestrogen receptor in human breast cancer, Int J Clin Lab Res, 22, 52, 10.1007/BF02591395 Marsigliante, 1992, Steroid receptor status in malignant and non-malignant larynx, Ann Oncology, 3, 387, 10.1093/oxfordjournals.annonc.a058213 Mattox, 1984, Androgen receptors and antiandrogen therapy for laryngeal carcinoma, Arch Otolaryngol, 110, 721, 10.1001/archotol.1984.00800370023005 Schuller, 1984, Oestrogen and progesterone receptors in head and neck cancer, Arch Otolaryngol, 110, 725, 10.1001/archotol.1984.00800370027006 Virolainen, 1984, Steroid hormone receptors in human squamous carcinoma cell lines, Int J Cancer, 33, 19, 10.1002/ijc.2910330105 van Noorden, 1986, Tissue preparation and immunostaining techniques for light microscopy, 47 Brouillet, 1990, Cathepsin D assay in primary breast cancer and lymph nodes: relationship with c-myc, c-erb-B-2 and int-2 oncogene amplification and node invasiveness, Eur J Cancer, 26, 437, 10.1016/0277-5379(90)90012-I Scambia, 1991, Cathepsin D assay in ovarian cancer: correlation with pathological features and receptors for oestrogen, progesterone and epidermal growth factor, Br J Cancer, 64, 182, 10.1038/bjc.1991.266 Spyratos, 1989, Cathepsin D: an independent prognostic factor for metastasis of breast cancer, Lancet, ii, 1115, 10.1016/S0140-6736(89)91487-6 Bradford, 1976, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindings, Anal Biochem, 72, 248, 10.1016/0003-2697(76)90527-3 Garcia, 1986, Distribution of the Mr 52,000 Oestrogen-related protein in benign breast diseases and other tissues by immunohistochemistry, Cancer Res, 46, 3734 Maudelonde, 1990, Cathepsin D in human endometrium: induction by progesterone and potential value as a tumor marker, J Clin Endocrinol Metab, 70, 115, 10.1210/jcem-70-1-115 Shuja, 1991, Cysteine endopeptidase activity levels in normal human tissues, colorectal adenomas and carcinomas, Int J Cancer, 49, 341, 10.1002/ijc.2910490305 Saku, 1990, Cathepsins D and E in normal, metaplastic, dysplastic and carcinomatous gastric tissue: an immunohistochemical study, Gut, 31, 1250, 10.1136/gut.31.11.1250 Robson, 1990, Immunolocalization of cathepsin D in the human central nervous system neoplasms, Neuropathol Appl Neurobiol, 16, 39, 10.1111/j.1365-2990.1990.tb00930.x Rochefort, 1989, Oestrogen-induced pro-cathepsin D in breast cancer. From biology to clinical applications, 95B, 107 Romain, 1990, Cathepsin D: an independent prognostic factor in cancer of the breast, Bull Cancer, 77, 439 Rochefort, 1992, Cathepsin D in breast cancer: a tissue marker associated with metastasis, Eur J Cancer, 28A, 1780, 10.1016/0959-8049(92)90003-K